Data Entry: Please note that the research database will be replaced by UNIverse by the end of October 2023. Please enter your data into the system https://universe-intern.unibas.ch. Thanks

Login for users with Unibas email account...

Login for registered users without Unibas email account...

 
Maximising Impact of Disease Modifying Antirheumatic Drugs in Rheumatoid Arthritis with the Use of Biomarkers (SQUEEZE)
Third-party funded project
Project title Maximising Impact of Disease Modifying Antirheumatic Drugs in Rheumatoid Arthritis with the Use of Biomarkers (SQUEEZE)
Principal Investigator(s) De Geest, Sabina M.
Project Members Kocher, Agnes
Organisation / Research unit Departement Public Health / Institut für Pflegewissenschaft,
Departement Public Health / Pflegewissenschaft (De Geest)
Department Departement Public Health
Project start 01.01.2023
Probable end 31.12.2027
Status Active
Abstract

The work programme proposed by the SQUEEZE consortium is a truly interrelated collaboration of leading centres in Europe that have come together for synergy and added value for addressing the objectives in a way that each one alone would not be able to. Within SQUEEZE WP#8, we will develop a novel eHealth-facilitated care model which includes personalised digital biomarkers to increase DMARDs effectiveness through optimized patient’s medication adherence and patient/clinician’s shared decision making. The participative and systematic approach has promising potential to improve the health outcomes of this population and – if proven effective – be a game changer in the lives of people with RA.

Financed by Commission of the European Union
   

MCSS v5.8 PRO. 0.429 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
20/04/2024